BSQR 2005Blood Safety and Quality Regulations 2005 (UK)
BSQR 2005 is the UK statutory instrument (SI 2005/50, as amended) that sets the legal requirements for collecting, testing, processing, storing and distributing human blood and blood components, enforced by the MHRA through authorisation, inspection and serious-incident reporting via SABRE.

On this page · 7 sections
- 1What BSQR 2005 is and where it comes from
- 2Scope: blood establishments, hospital blood banks and blood facilities
- 3Quality system requirements
- 4Traceability and the 30-year retention period
- 5Serious-incident reporting through SABRE
- 6Authorisation and the MHRA inspection regime
- 7What BSQR 2005 means for blood and tissue operations software
How does BSQR 2005 apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What BSQR 2005 is and where it comes from
The Blood Safety and Quality Regulations 2005 were made on 13 January 2005, laid before Parliament on 18 January 2005, and came into force on 8 February 2005 for all purposes other than regulation 25(1), which came into force later, on 8 November 2005. They are a statutory instrument of the UK Parliament, numbered SI 2005/50, made under powers in the European Communities Act 1972 by the Secretary of State for Health, who at the time was a minister designated to transpose European health-protection measures regulating the use of material of human origin into UK law.
The regulations were originally the UK's transposition of the EU Blood Directive framework, principally Directive 2002/98/EC and its technical daughter directives, including Commission Directive 2005/62/EC on quality systems for blood establishments. Since the UK's departure from the EU, the regulations have continued in force as retained and amended domestic law, with amendments reflecting the end of direct application of EU directives and giving effect instead to UK-specific good practice guidance referenced within the regulations themselves, such as the Guide to the preparation, use and quality assurance of blood components published in its 20th edition. Readers relying on the text should check the current, amended version on legislation.gov.uk rather than the original 2005 "as made" text, since several of the operative provisions, including the quality system and record-keeping requirements, have been substituted since 2005.
BSQR 2005 sits alongside, but is distinct from, the Human Tissue Act 2004 and the Human Tissue (Quality and Safety for Human Application) Regulations 2007, which cover tissues and cells rather than whole blood and blood components. An organisation that handles both blood and tissue material, for example a hospital that runs a blood bank and a tissue bank, needs to track both regimes, because the two sets of regulations define overlapping but not identical obligations, inspecting authorities and record-keeping periods.
02Scope: blood establishments, hospital blood banks and blood facilities
BSQR 2005 draws a central distinction between a blood establishment and a hospital blood bank, and the duties placed on each differ in detail even though both are regulated under the same instrument. The regulations define a blood establishment as any person, other than a person responsible for management of a hospital blood bank, that collects, tests or processes human blood or blood components, whatever their intended purpose, and that distributes them for transfusion. In the UK this role is carried out principally by the four UK blood services, such as NHS Blood and Transplant in England, which collect donations, test them, process them into components and release them for clinical use.
A hospital blood bank, by contrast, is a hospital-based unit that stores, and in some cases tests and distributes, human blood and blood components, generally for use within that hospital, including for transfusion. Hospital blood banks do not usually collect blood from donors; they receive components already prepared and released by a blood establishment and are responsible for storage, pre-transfusion testing, compatibility testing, issue to clinical areas and the hospital end of traceability. MHRA guidance also describes blood facilities more broadly as sites that collect, test and supply human blood or blood components intended for transfusion, a description that in practice covers both blood establishments and hospital blood banks for the purposes of the authorisation and inspection regime the MHRA administers.
Because the quality system, documentation and traceability obligations in BSQR 2005 are expressed separately for blood establishments (regulation 8 and related provisions) and for hospital blood banks (regulation 9), a software system supporting a blood facility needs to be configured against the correct regulatory role for that site, since a single hospital trust may operate a hospital blood bank for transfusion services while also hosting, for example, a cord blood or stem cell activity regulated under a different framework entirely.
03Quality system requirements
Regulation 9 requires the person responsible for managing a hospital blood bank to ensure that personnel directly involved in testing, storage and distribution of blood and blood components are suitably qualified and are given timely, relevant and regularly updated training, and to establish and maintain a quality system for the hospital blood bank. As amended, that quality system must, for Great Britain, be based on the principles of good practice meeting the standards set out in the Annex to Commission Directive 2005/62/EC and give effect to the Good Practice Guidelines for Blood Establishments published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components; a parallel but separately worded obligation applies in Northern Ireland. Equivalent quality system obligations apply to blood establishments.
Regulation 9 also requires validation of the processes set out in Part 4 of the Schedule that are applicable to the hospital blood bank's own activities, and requires documentation on operational procedures, guidelines, training records and reporting forms to be maintained and kept readily available for inspection under regulation 15. This documentation-and-validation structure is consistent with the broader GMP-style quality system concept used elsewhere in pharmaceutical and medical device regulation: written procedures, validated processes, trained and qualified personnel, and records that an inspector can review on demand.
What a quality system typically has to demonstrate
- Documented standard operating procedures covering collection, testing, processing, storage, distribution, or (for hospital blood banks) receipt, storage and issue of blood and blood components
- Personnel training records showing staff performing these tasks are qualified and kept up to date
- Validation records for applicable processes under the Schedule to the regulations
- A system for recording and investigating deviations, non-conformances and quality issues
- Records retained and organised so they are readily available for MHRA inspection
04Traceability and the 30-year retention period
Traceability is one of the most specific and software-relevant obligations in BSQR 2005. Regulation 8 requires a blood establishment to label each unit of blood or blood component it supplies, or imports, with a defined set of particulars, including the official name of the component, its volume, weight or cell count, a unique numeric or alphanumeric donation identifier, the name of the producing blood establishment, the ABO and Rh D group where applicable, expiry date or time, storage temperature, and the name, composition and volume of any anticoagulant or additive solution. Beyond labelling, regulation 8(2) requires a blood establishment to keep records of that labelling information, together with such additional records as are necessary to identify each single blood donation and each single blood unit and its components, and to ensure full traceability to the point of delivery to a hospital, for a period of not less than 30 years 3.
Regulation 9, as amended, places a corresponding retention duty on hospital blood banks: the person responsible for a hospital blood bank must maintain, in an appropriate and readable storage medium, and for a period of not less than 30 years, the data set out in Part 6 of the Schedule to the extent it applies, supporting traceability from the hospital end of the chain back to the donation 2. Taken together, these two provisions are what practitioners usually mean when they refer to "donor to patient, patient to donor" traceability under BSQR 2005: a record trail that can be followed in either direction, from an individual donation through to the patient who received a component made from it, and maintained for three decades.
For a software system, this retention obligation has practical implications beyond simple data storage. Records need to remain readable and retrievable for the full period even as software versions, database platforms and organisations change, which in practice means export formats, archival strategy and long-term data integrity controls matter as much as the initial capture of the data. A system that captures donation numbers, component identifiers, testing results and issue-to-patient records at the point of activity, and links them so that a query can move from a donation number to every patient who received a component from it (and back), is addressing the substance of what regulation 8 and regulation 9 require, though the retention period itself is a records-management and archiving responsibility that sits alongside, not instead of, the software's data model.
05Serious-incident reporting through SABRE
BSQR 2005 requires blood establishments and hospital blood banks to report serious adverse reactions in donors or recipients and serious adverse events connected with the collection, testing, processing, storage or distribution of blood and blood components. In practice this reporting obligation is operationalised through SABRE, the Serious Adverse Blood Reactions and Events reporting system, which the MHRA operates as the online route for mandatory haemovigilance reporting in the UK 1. Organisations register with SABRE by organisation type, for example as a blood establishment or a hospital blood bank/transfusion team, and nominate personnel authorised to submit reports on the organisation's behalf.
The joint UK haemovigilance user guide produced by MHRA and the independent Serious Hazards of Transfusion (SHOT) scheme sets out the legal framework for reporting, distinguishes serious adverse reactions (SAR) in donors or recipients from serious adverse events (SAE) connected with processes, and describes a notification-then-confirmation reporting workflow within the online system, with defined categorisation of events and provision for referral to MHRA inspectors where appropriate 4. SHOT itself is a separate, long-running professionally led haemovigilance scheme that works alongside the statutory SABRE reporting route, and UK organisations are expected to engage with both the mandatory regulatory reporting and the professional haemovigilance reporting it complements.
What this means for an organisation's internal processes
- Detect and categorise the incident internally as a potential serious adverse reaction or serious adverse event
- Determine reportability against the SAR/SAE definitions used in SABRE and the haemovigilance user guide
- Submit a notification report through the SABRE system within the organisation's registered account
- Follow up with a confirmation report and, where applicable, root-cause and corrective-action information
- Retain the internal investigation record alongside the traceability data linking the incident to the relevant donation or unit
A system that supports blood or hospital blood bank operations can usefully flag conditions that commonly trigger SAR/SAE assessment, such as a transfusion reaction recorded against a unit, a near-miss in patient identification, or a deviation found during storage or testing, and can hold the internal incident record in a way that links directly to the donation and unit records it concerns. The actual submission into SABRE, however, is made through the MHRA's own online reporting system by registered personnel, so software supporting this area should be described as helping an organisation prepare, track and evidence its SABRE reporting obligations, rather than as submitting or completing them on the organisation's behalf.
07What BSQR 2005 means for blood and tissue operations software
Software used in blood establishment or hospital blood bank operations sits close to several distinct obligations under BSQR 2005 rather than a single unified requirement, and it helps to treat them separately when assessing or configuring a system.
| BSQR 2005 obligation | Typical software-relevant capability |
|---|---|
| Quality system (regulations on blood establishments and hospital blood banks) | Document control, SOP management, training records, deviation and CAPA tracking |
| Traceability and 30-year retention (regulation 8, regulation 9) | Donation-to-unit-to-patient linkage, durable record storage, long-term export and archival support |
| Labelling particulars (regulation 8(1)) | Accurate capture and printing of donation number, ABO/Rh D group, component name, expiry and storage conditions |
| Serious-incident reporting (supported by SABRE) | Internal incident logging linked to unit records, to help an organisation prepare SABRE notification and confirmation reports |
| Inspection readiness (regulation 15) | Retrievable, organised evidence of quality system operation, training and traceability for MHRA inspectors |
A system cannot itself make an organisation compliant with BSQR 2005, because compliance depends on how the organisation operates, trains staff, validates its processes and responds to findings, as well as on the software it uses. What software can reasonably be expected to do is support the record-keeping, traceability linkage and documentation retrieval that the regulations describe, and make it easier for an organisation to demonstrate, at inspection, that its quality system is operating as designed. Organisations evaluating software for blood establishment or hospital blood bank use should ask specifically how donation-to-patient traceability is modelled, how long records are retained and in what format, how the system supports the organisation's own SABRE reporting workflow, and how training and validation records are linked to the personnel and processes they cover.
Because BSQR 2005 is UK-specific and has been amended since its original 2005 text, including changes reflecting the end of direct EU-derived obligations after Brexit, organisations and vendors should check the current, amended version of the regulations on legislation.gov.uk, and current MHRA guidance on GOV.UK, before relying on any summary, including this one, as a complete statement of a particular site's obligations.
Frequently asked questions
Q.What is the difference between a blood establishment and a hospital blood bank under BSQR 2005?+
A blood establishment collects, tests or processes human blood or blood components and distributes them for transfusion, a role carried out in the UK principally by the national blood services. A hospital blood bank is a hospital-based unit that stores, and in some cases tests and issues, blood and blood components it has received from a blood establishment, generally for use within that hospital. BSQR 2005 places related but separately worded obligations on each role, in regulations covering blood establishments and in regulation 9 covering hospital blood banks.
Q.How long must traceability records be kept under BSQR 2005?+
Regulation 8 requires a blood establishment to keep the records needed to identify each single blood donation and unit and to ensure full traceability to the point of delivery to a hospital for a period of not less than 30 years. The amended regulation 9 places a corresponding 30-year retention duty on hospital blood banks for the data set out in Part 6 of the Schedule, as confirmed by the current text on legislation.gov.uk.
Q.What is SABRE and who has to report to it?+
SABRE, Serious Adverse Blood Reactions and Events, is the MHRA's online system for reporting serious adverse reactions in donors or recipients and serious adverse events connected with the collection, testing, processing, storage or distribution of blood and blood components. Blood establishments and hospital blood banks register with SABRE and report through it as part of meeting their statutory reporting obligations, alongside the related professional haemovigilance scheme, SHOT.
Q.Does BSQR 2005 still apply in the UK after Brexit?+
Yes. BSQR 2005 is a UK statutory instrument that continues in force as amended domestic law. It originally transposed EU directives on blood safety and quality, and it has since been amended, including to reflect the end of direct application of EU directives, with the regulations now referencing UK-specific good practice guidance for the quality system requirements. The current, amended text should be checked on legislation.gov.uk rather than the original 2005 version.
Q.Can software make a blood bank or blood establishment compliant with BSQR 2005?+
No single piece of software achieves compliance on its own, because BSQR 2005 compliance depends on how an organisation trains staff, validates processes, maintains its quality system and responds to inspection findings, in addition to the tools it uses. Software can support the record-keeping, donation-to-patient traceability, retention and documentation retrieval that the regulations describe, which is a meaningful part of demonstrating compliance at MHRA inspection, but the organisation's own procedures and practice remain central.
Primary sources
- The Blood Safety and Quality Regulations 2005, SI 2005/50 (legislation.gov.uk, original "made" text) — reviewed 9 Oct 2026
- SI 2005/50, regulation 8 — Labelling of blood and blood components and traceability (legislation.gov.uk) — reviewed 9 Oct 2026
- SI 2005/50, regulation 9 — Hospital blood bank requirements, as amended (legislation.gov.uk) — reviewed 9 Oct 2026
- MHRA, Blood: authorisations and safety reporting (GOV.UK guidance) — reviewed 9 Oct 2026
- MHRA/SHOT, User guide for mandatory and professionally mandated haemovigilance reporting in the UK, January 2024 (shotuk.org) — reviewed 9 Oct 2026
- SHOT, Incident reporting / SABRE login portal (shotuk.org) — reviewed 9 Oct 2026
Further reading
Want to see how BSQR 2005 could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
